Avinger Inc Quick Ratio (AVGR) starting from the third quarter 2024 to third quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Avinger Inc   (NASDAQ: AVGR)

Avinger Inc 's Quick Ratio

AVGR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2024, Quick Ratio fell to 0.62 below Avinger Inc average.

Within Medical Equipment & Supplies industry 131 other companies have achieved higher Quick Ratio than Avinger Inc in third quarter 2024. While Quick Ratio total ranking in the third quarter 2024 has deteriorated compared to the prior quarter from 834 to 2016.

Explain Quick Ratio?
How much Cash & cash equivalents AVGR´s has?
What are AVGR´s Current Liabilities?




AVGR Quick Ratio (Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
(Dec 31 2023)
Q4
(Sep 30 2023)
Q3
Y / Y Current Liabilities Change -39.32 % -66.88 % -4.19 % 13.76 % 203.04 %
Y / Y Cash & cash equivalent Change -18.04 % 23.56 % -30.82 % -63.88 % -58.48 %
Quick Ratio MRQ 0.62 1.37 0.42 0.29 0.46
AVGR's Total Ranking # 2016 # 834 # 2756 # 2962 # 166
Seq. Current Liabilities Change 48.37 % -62.1 % -7.13 % 16.2 % -19.02 %
Seq. Cash & cash equivalent Change -32.99 % 22.75 % 36 % -26.74 % 1.02 %



Quick Ratio third quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 132
Healthcare Sector # 712
Overall Market # 2016


Quick Ratio Statistics
High Average Low
9.28 2.14 0.11
(Sep 30 2015)   (Dec 31 2017)




Financial Statements
Avinger Inc 's Current Liabilities $ 10 Millions Visit AVGR's Balance sheet
Avinger Inc 's Cash & cash equivalent $ 6 Millions Visit AVGR's Balance sheet
Source of AVGR's Sales Visit AVGR's Sales by Geography


Cumulative Avinger Inc 's Quick Ratio

AVGR's Quick Ratio for the trailling 12 Months

AVGR Quick Ratio

(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
(Sep 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth -25.69 % -1.69 % 63.16 % 145.94 % 346.51 %
Y / Y Cash & cash equivalent TTM Growth -30.9 % -42.45 % -54.11 % -55.92 % -46.08 %
Quick Ratio TTM 0.53 0.5 0.38 0.42 0.57
Total Ranking TTM # 3566 # 3425 # 1627 # 2798 # 291
Seq. Current Liabilities TTM Growth -10.77 % -18.45 % -1.04 % 3.21 % 18.05 %
Seq. Cash & cash equivalent TTM Growth -4.57 % 6.27 % -10.66 % -23.74 % -20.51 %


On the trailing twelve months basis Current Liabilities decreased faster than Avinger Inc 's average Cash & cash equivalent, this led to increase in in Avinger Inc 's Quick Ratio to 0.53, Quick Ratio remained below AVGR average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 213 other companies have achieved higher Quick Ratio than Avinger Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2024 from 3425 to 3566.

Explain Quick Ratio?
How much Cash & cash equivalents AVGR´s has?
What are AVGR´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 214
Healthcare Sector # 954
Within the Market # 3566


trailing twelve months Quick Ratio Statistics
High Average Low
3.85 1.33 0.27
(Dec 31 2021)   (Dec 31 2017)




Companies with similar Quick Ratio in the quarter ending Sep 30 2024, within Medical Equipment & Supplies Industry Quick RatioSep 30 2024 MRQ Cash & cash equivalentSep 30 2024 MRQ Current Liabilities
Nyxoah Sa  1.59 $ 38.288  Millions$ 24.113  Millions
Lensar Inc   1.55 $ 18.080  Millions$ 11.678  Millions
Longduoduo Co Ltd  1.53 $ 0.361  Millions$ 0.236  Millions
Genedx Holdings Corp   1.51 $ 116.460  Millions$ 77.342  Millions
Allurion Technologies Inc   1.49 $ 28.654  Millions$ 19.244  Millions
Novocure Limited  1.48 $ 959.898  Millions$ 648.652  Millions
Carlisle Companies Incorporated  1.47 $ 1,530.600  Millions$ 1,040.700  Millions
U S Physical Therapy Inc  1.45 $ 116.959  Millions$ 80.472  Millions
Koru Medical Systems Inc   1.39 $ 8.806  Millions$ 6.324  Millions
Cerus Corporation  1.39 $ 75.565  Millions$ 54.345  Millions
Strata Critical Medical Inc   1.35 $ 21.605  Millions$ 16.028  Millions
Polypid Ltd  1.33 $ 15.641  Millions$ 11.762  Millions
Alphatec Holdings Inc   1.32 $ 80.976  Millions$ 61.368  Millions
Si bone inc   1.29 $ 30.225  Millions$ 23.474  Millions
Milestone Scientific Inc   1.27 $ 4.776  Millions$ 3.758  Millions
Sonoma Pharmaceuticals Inc   1.23 $ 4.078  Millions$ 3.309  Millions
Vivos Therapeutics Inc   1.23 $ 6.311  Millions$ 5.126  Millions
Heartsciences Inc   1.23 $ 4.052  Millions$ 3.303  Millions
FAMILY OFFICE OF AMERICA, INC.  1.20 $ 0.047  Millions$ 0.039  Millions
Ceribell Inc   1.18 $ 14.110  Millions$ 11.955  Millions
Axogen inc   1.16 $ 24.530  Millions$ 21.177  Millions
Envista Holdings Corporation  1.15 $ 991.300  Millions$ 865.500  Millions
Trisalus Life Sciences Inc   1.14 $ 11.288  Millions$ 9.918  Millions
Sanara Medtech Inc   1.14 $ 16.277  Millions$ 14.340  Millions
Haemonetics Corporation  1.09 $ 299.283  Millions$ 273.946  Millions
Semler Scientific inc   1.09 $ 6.568  Millions$ 6.034  Millions
Biolife Solutions Inc   1.06 $ 34.188  Millions$ 32.166  Millions
Ir med Inc   1.04 $ 0.392  Millions$ 0.376  Millions
Cutera Inc   1.03 $ 57.614  Millions$ 55.689  Millions
Pro dex Inc   1.03 $ 7.819  Millions$ 7.566  Millions

Date modified: 2026-09-08T15:11:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.